Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-11-06

Clinical Trial Update: Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial comparing duloxetine with placebo in adults with generalized anxiety disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cymbalta (duloxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Anxiety Disorders | Phase 3 | Status: COMPLETED